Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2005 R33 RFA-CA-05-002 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN MADISON SINGLE MOLECULE GENOME ANALYSIS OF OLIGODENDROGLIOMA Complete
2015 R33 RFA-CA-14-004 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS VALIDATION AND ADVANCED DEVELOPMENT OF GLYCAN NODE ANALYSIS IN LUNG CANCER RESEARCH Complete
2010 R33 RFA-CA-09-007 KENIS, PAUL J. A. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN FRET-BASED BIOSENSORS TO MONITOR REDOX IN CELL CYCLE REGULATION Complete
2014 R33 RFA-CA-13-004 TURESKY, ROBERT J. UNIVERSITY OF MINNESOTA CARCINOGEN DNA ADDUCT BIOMARKERS IN FORMALIN FIXED TISSUES Complete
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes Active
2001 R33 PAR-99-100 SIKIC, BRANIMIR I STANFORD UNIVERSITY GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS Complete
2013 R33 RFA-CA-12-005 SCHLEGEL, RICHARD GEORGETOWN UNIVERSITY CONDITIONALLY REPROGRAMMED CELLS AS A NOVEL TOOL FOR BIOBANKING Complete
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE
2012 R33 RFA-CA-12-005 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTRAP TECHNOLOGY FOR ONE STEP PRESERVATION AND AMPLIFICATION OF CANCER BIOMARK Complete
2019 R33 RFA-CA-18-003 DE VLAMINCK, IWIJN CORNELL UNIVERSITY Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer Active
2002 R33 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2005 R33 RFA-CA-05-002 BAKER, JAMES R UNIVERSITY OF MICHIGAN AT ANN ARBOR PHOTONIC CRYSTAL FIBER PROBE FLUORESCENCE BIOSENSING Complete
2015 R33 RFA-CA-14-004 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY SINGLE CELL GROWTH ASSAY FOR RESIDUAL CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA Complete
2018 R33 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2017 R33 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research Active
2001 R33 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2019 R33 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
2010 R33 RFA-CA-09-007 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT DISCOVERY PLATFORM FOR CANCER ANTIGENS Complete
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES Active
2001 R33 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2013 R33 RFA-CA-13-002 BROWN, BRIAN DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. Complete
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA HOW DO COLORECTAL CANCERS ARISE DESPITE SURVEILLANCE? Complete
2008 R33 RFA-CA-07-034 POOLE, LESLIE B. WAKE FOREST UNIVERSITY HEALTH SCIENCES PROTEOMIC PROFILING OF CANCER-RELATED REDOX SIGNALING PATHWAYS Complete
2015 R33 RFA-CA-14-004 ZHU, HENG JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF A VIRION DISPLAY (VIRD) ARRAY TO PROFILE HUMAN GPCR INTERACTIONS Complete
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity Active
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2009 R21 RFA-CA-08-006 LARSON, DALE N CHARLES STARK DRAPER LABORATORY THE DEVELOPMENT OF A CHIP-SCALE NANO-CALORIMETER Complete
2013 R21 RFA-CA-12-002 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE OPTIMIZATION OF MULTIVALENT LIGANDS BY SUPER-RESOLUTION MICROSCOPY TO TREAT CANCE Complete
2000 R21 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2002 R21 PAR-01-104 HEYDUK, TOMASZ SAINT LOUIS UNIVERSITY MOLECULAR BEACONS FOR PROTEIN DETECTION Complete
2005 R21 RFA-CA-05-002 MURPHY, JOHN R. BOSTON MEDICAL CENTER NOVEL TARGETED REAGENTS THAT MODIFY ONCOGENE EXPRESSION Complete
2015 R21 RFA-CA-14-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN DROPLET MICROFLUIDIC PLATFORM FOR ULTRALOW INPUT EPIGENETICS Complete
1999 R21 PAR-98-067 BENSIMON, AARON PASTEUR INSTITUTE DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING Complete
2007 R21 RFA-CA-07-002 SHEA, LONNIE D NORTHWESTERN UNIVERSITY TRANSFECTED CELL ARRAYS FOR CANCER RESEARCH Complete
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2009 R21 RFA-CA-08-006 SHAPIRO, BENJAMIN UNIV OF MARYLAND, COLLEGE PARK SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS Complete
2013 R21 RFA-CA-12-002 SOPER, STEVEN ALLAN UNIV OF NORTH CAROLINA CHAPEL HILL ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY Complete
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Active
2000 R21 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2002 R21 PAR-01-104 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE PAP: A TECHNOLOGY PLATFORM Complete

Pages